CLANOBUTIN SODIUM

Details

Stereochemistry	ACHIRAL
Molecular Formula	C18H17ClNO4.Na
Molecular Weight	369.775
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Na+].COC1=CC=C(C=C1)N(CCCC([O-])=O)C(=O)C2=CC=C(Cl)C=C2

InChI

InChIKey=XLGYRQNAXHSHGM-UHFFFAOYSA-M

InChI=1S/C18H18ClNO4.Na/c1-24-16-10-8-15(9-11-16)20(12-2-3-17(21)22)18(23)13-4-6-14(19)7-5-13;/h4-11H,2-3,12H2,1H3,(H,21,22);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula	Na
Molecular Weight	22.98976928
Charge	1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C18H17ClNO4
Molecular Weight	346.785
Charge	-1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7341779 | https://www.ejmanager.com/mnstemps/31/31-1529690670.pdf

Clanobutin is a choleretic drug. It increases the secretion of bile by hepatocytes. Clanobutin sodium has been introduced as a choleretic and digestant agent for animals. It has been used in all domestic animals in which enhancement of digestion and all associated secretory processes are indicated. Clanobutin was reported to induce a demonstrable increase in the secretory activity of the exocrine digestive glands and in the excretion of the bile.

Approval Year

PubMed

Title	Date	PubMed
Nonfatal splenic haematoma and pancytopenia in an ass.	2004-08	15359962

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:24:43 GMT 2025` Edited by `admin` on `Mon Mar 31 21:24:43 GMT 2025`
Record UNII	61W1PEJ7VS
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CLANOBUTIN SODIUM

Common Name

English

BUTANOIC ACID, 4-((4-CHLOROBENZOYL)(4-METHOXYPHENYL)AMINO)-, SODIUM SALT (1:1)

Preferred Name

English

Code System Code Type Description

ECHA (EC/EINECS)

277-987-1